Since 1979, continuous ambulatory peritoneal dialysis (CAPD) has developed as an important modality of therapy for patients with end-stage renal disease (12, 16) . However, peritonitis continues to be a major risk factor for patients on CAPD (2, 6, 15, 24) . Infections in patients who are receiving CAPD are usually treated by the intraperitoneal administration of antimicrobial agents. To minimize the risk of introducing organisms into bags of peritoneal dialysis solution (PDS), we give patients premixed bags of PDS to which antimicrobial agents have been added by the nursing or pharmacy staff. Patients receive a premixed 2-to 3-day supply and are requested to return to the center for an additional supply, as needed.
Surprisingly, few data are available concerning the stability of antimicrobial agents in PDS beyond 48 h (4, 8, 19, 26) . Our investigation was designed to test the in vitro efficacy of this procedure. Specifically, aminoglycosides have been reported to complex chemically with beta-lactam antimicrobial agents in a time-dependent reaction (7, 13, 14, 17, 18, (21) (22) (23) Antimicrobial agents. Cefazolin (125 ,ug/ml; Eli Lilly & Co., Indianapolis, Ind.) and gentamicin (4 ,ug/ml; ElkinsSinn Inc., Cherry Hill, N.J.) were added to six PDS bags of 1.5 and 4.5% Dianeal, respectively; or gentamicin (8 ,ug/ml) alone was added to six bags of 1.5% Dianeal and mixed thoroughly. Samples were collected at 6 and 72 h and tested within 1 h for osmolarities (Precision Systems, Natick, Mass.) and gentamicin levels (EMIT; Syva Corp., Palo Alto, Calif.). Bactericidal activities were tested by using a biological system. In addition, gentamicin (8 ji.g/ml) or imipenem (4 ,ug/ml; Merck Sharp & Dohme, West Point, Pa.) was added to PDE that was inoculated 2 h earlier with a standardized bacterial suspension. Samples were collected at 6 and 10 h after the addition of the antimicrobial agent and tested for bactericidal activity.
Bactericidal test. The antimicrobial activity of PDS or PDE with and without the antimicrobial agent was measured directly by using fresh isolates of ATCC strains of the three most common bacteria that cause peritonitis in our institution, i.e., P. aeruginosa ATCC 27853, S. aureus ATCC 29213, and S. epidermidis ATCC 12228. MICs of gentamicin for the strains were <2, <0.5, and <0.5 pLg/ml, respectively.
The proposed National Committee for Clinical Laboratory Standards guideline (10) for the bactericidal tests in serum was used with modifications. Briefly, 50 ml of PDS with and without the antimicrobial agent was removed from the peritoneal dialysis bags, placed in 50-ml centrifuge tubes (Falcon 2098; Becton Dickinson Labware, Lincoln Park, N.J.), and submitted for testing.
By using a separate sterile pipette tip (Medical Laboratory Automation, Inc., Mount Vernon, N.Y.), serial twofold dilutions (1:2 through 1:2,048) of PDS in Mueller-Hinton (MH) broth supplemented with calcium and magnesium (09-597; Remel, Lenexa, Kans.) were prepared by using sterile, 10-ml tubes without anticoagulant (6442; Vacutainer; Becton Dickinson Labware). The organisms were grown in supplemented MH broth at 35°C until they were visibly turbid, i.e., 3 to 5 h, when they reached the midlogarithmic phase, and were then adjusted to a turbidity visually comparable to that of a 0.5 McFarland standard. Except for the negative control, the bacterial suspensions were immediately inoculated into each tube of PDS plus MH broth. Two positive controls, i.e., an organism plus MH broth or PDS, were tested in parallel. The final inoculum per tube contained ca. 5 x 10' CFU/ml. The tubes, along with a pure subculture of the bacterial inoculum, were incubated in an incubator without CO2 at 35°C for 20 h. The tubes were then shaken by hand, reincubated, and shaken again before samples were obtained at 24 h. The static level, i.e., the last dilution that showed no visible growth, was recorded. Each tube that showed no growth and all controls were subcultured onto blood agar plates (BBL Microbiology Systems, Cockeysville, Md.) by using a 0.01-ml sterile, calibrated loop (Nunc, Roskilde, Denmark). The plates were incubated for 18 to 24 h at 35°C, and the bactericidal level, i.e., the last dilution at which 99.9% of the initial inoculum was killed, was determined.
Each organism suspension, which was adjusted as outlined above, was added to six sterile containers (Simport Plastics, Beloeil, Quebec, Canada) with 50 ml of uninfected PDE to give a final inoculum of ca. 5 x 105 CFU/ml. Following incubation for 2 h at 35°C, each container was subcultured; i.e., a baseline reading was obtained. Gentamicin or imipenem was added to five of the six containers with each of the three ATCC strains. The remaining container was used as a positive control with an organism. All containers were subcultured for bactericidal activity at 6 and 10 h following the addition of the antimicrobial agent.
RESULTS

Tables 1 and 2 demonstrate the in vitro bactericidal
acivities of a combination of cefazolin and gentamicin in both 1.5 and 4.25% Dianeal fluid when tested against S. aureus and S. epidermidis, but not against P. aeruginosa, at 6 and 72 h. Gentamicin was detected quantitatively by using the EMIT system and therefore was not altered chemically by exposure to cefazolin. Likewise, gentamicin alone gave essentially the same results ( >200  >200  >200  >200  >200  >200  >200  >200  >200  >200  2  NGb  >200c  =50  NG  NG  NG  NG  NG  >200  >200  >200  >3  3  NG  NG  27  1  NG  NG  NG  NG   >200  >200  >200  >8  4  NG  NG  33  NG  NG  NG   1  NG  >200  >200  >200  >8  5  NG  NG  28  1  NG  NG  1  NG  >200  >200  >200  >7  6  NG  NG  29  NG  NG  NG  NG  NG  >200  >200  >200  >3 Baseline counts for all organisms (i.e., at 2 h postinoculation) were >200 colonies per plate. b NG, No growth. ' Probable technical error.
less than that of gentamicin (Table 4) , and to have modest activity against P. aeruginosa.
DISCUSSION
Based on the findings of this study, gentamicin does not appear to be altered chemically or biologically by either cefazolin or PDS since it was quantitatively present when determined with the EMIT system and was biologically active against S. aureus and S. epidermidis after exposure for 6 and 72 h. Immunologic and other host-derived factors such as divalent cation levels, oxidation-reduction potential, protein, and the pH present in sterile PDE after a 9-h dwell time did not appear to improve the bactericidal activity of gentamicin against P. aeruginosa. Under the same conditions, imipenem demonstrated significant bactericidal activity against P. aeruginosa.
The lack of bactericidal activity by gentamicin did not appear to be related to the medium that was used in the assay, as has been reported by Shalit et al. (20) . Gentamicin showed little or not activity in vitro when either MH broth or PDE, both of which contained calcium and magnesium, was used. Both of these divalent cations tended to lower the MICs for aminoglycosides when they were included in MH broth (9) , even though they did not appear to influence the susceptibility of P. aeruginosa to gentamicin in our system. PDS was not used as the diluent in the assay because of previous reports of its failure to support growth or aminoglycoside activity (1, 3, 25) . According to Kane et al. (5) , gentamicin may attach to the bags, particularly those containing 4.25% glucose solution, which may account for the altered quantitative activity, biological activity, or both. To eliminate this possibility, we removed PDE from the bag prior to the addition of organisms and antimicrobial agents. In addition, there was no apparent phenotypic change in the strain of P. aeruginosa after exposure to MH broth, PDE, or PDS that could explain the phenomenon that was observed.
In summary, undefined factors, other than inactivation of gentamicin, may be responsible for the lack of activity against P. aeruginosa. The unique characteristics of P. aeruginosa may be responsible for this phenomenon, since both Staphylococcus spp. were killed by gentamicin in all solutions tested. Likewise, local or humoral factors in vivo, or the lack thereof, may not be the only reasons for the failure of bacterial cure of Pseudomonas peritonitis in patients on CAPD. As reported by Nguyen et al. (11) , cures may occur without catheter removal if patients are placed on early and prolonged courses of antibiotics, including a synergistic semisynthetic penicillin. 
